Bioforce Nanosciences Holdings BFNH

OTC BFNH
$6.90 -0.05 (-0.72%)
At close: Oct 15, 2026 · 4:00 PM EDT

Bioforce Nanosciences Holdings (BFNH) stock price is $6.90, down 0.72% on the day, as of Oct 15, 2026. It has a market cap of $234.47Mn, and is classified in the Personal Care Products industry (Consumer Staples sector).

Key Stats
Market Cap234.47 Mn
P/E-2,289.22
Div. Yield0.00
Add ratio to table…

About

BioForce Nanosciences Holdings, Inc. is engaged in the business of developing, marketing, and selling natural vitamins, minerals, and nutritional supplements, powders, and beverages aimed at promoting a healthier lifestyle for active individuals across all age groups. The company operates primarily through a private label model, offering its flagship product, BioForce Eclipse, a powdered multivitamin and mineral supplement, to retailers and distributors. It entered the…

Read more ↓
Sector: Consumer Staples Sector rationale The company develops and sells natural vitamins, minerals, and nutritional supplements, such as the BioForce Eclipse powder, which fall under the 'Personal Care Products' or 'Packaged Foods' categories of Consumer Staples. Its revenue is generated by selling these everyday health essentials to grocery stores, pharmacies, and supermarkets. Industries: Personal Care Products Personal Care Products Primary BioForce Nanosciences Holdings develops and sells natural vitamins, minerals, and nutritional supplements, specifically its flagship BioForce Eclipse powdered multivitamin. These products are sold as over-the-counter consumer health and wellness products to individuals and retail outlets. Non-Alcoholic Beverages Non-Alcoholic Beverages Secondary The company's business profile explicitly mentions the development, marketing, and selling of beverages aimed at promoting a healthier lifestyle for active individuals. Classified using BQ-MICS CIK: 0001310488
Peer percentiles

How Bioforce Nanosciences Holdings ranks

Ranked against the 60 companies in Household and Personal Products58 metrics · as of Oct 16, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings <−1,000xMedian 17.9x 58th
  • P/FCFNegative free cash flow <−1,000xMedian 18.9x 34th
  • P/Operating cash flowNegative operating cash flow <−1,000xMedian 11.7x 33rd
  • P/S —Median 1.56x No data —
  • P/B 101xMedian 2.35x 3rd
  • P/Tangible book 101xMedian 3.46x 3rd
  • EV/EBITDA —Median 12.4x No data —
  • EV/EBITNegative EBIT −374xMedian 13.3x 49th
  • EV/Revenue —Median 1.60x No data —
  • EV/FCFNegative free cash flow <−1,000xMedian 22.3x 35th
  • EV/Operating cash flowNegative operating cash flow <−1,000xMedian 18.0x 32nd
  • PEG (3Y EPS CAGR)Negative earnings −52.6Median 0.96 Not meaningful —
Peer group

Peer Comparison

Companies in the Personal Care Products
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 PG PROCTER & GAMBLE Co 367.79 Bn22.924.2334.14 Bn
2 CL Colgate Palmolive Co 74.66 Bn36.653.557.86 Bn
3 EL Estee Lauder Companies Inc 38.33 Bn210.592.557.31 Bn
4 KVUE Kenvue Inc. 36.21 Bn21.842.358.48 Bn
5 KMB Kimberly Clark Corp 35.02 Bn17.912.116.52 Bn
6 CHD Church & Dwight Co Inc /De/ 24.64 Bn33.093.962.26 Bn
7 CLX Clorox Co /De/ 10.41 Bn17.731.555.07 Bn
8 BFNH Bioforce Nanosciences Holdings, Inc. 0.23 Bn-2,289.22--